| Imaging brain glucose metabolism in vivo reveals propionate as a major anaplerotic substrate in pyruvate dehydrogenase deficiency I Marin-Valencia, A Kocabas, C Rodriguez-Navas, VZ Miloushev, ... Cell metabolism 36 (6), 1394-1410. e12, 2024 | | 2024 |
| [11C] MODAG 005–a novel PET tracer targeting alpha-synuclein aggregates in the brain RS Saw, S Buss, F Schmidt, S Ryazanov, A Leonov, L Kuebler, D Bleher, ... | | 2024 |
| [11C] MODAG 005–a novel PET tracer targeting alpha-synuclein aggregates in the brain K Herfert, S Buss, RS Saw, L Kuebler, F Schmidt, S Ryazanov, A Leonov, ... | | 2024 |
| A Highlight on Dr. Julie C. Price: an Exceptional Career and a Candid Conversation on Diversity, Equity, and Inclusion VL Nagle, OF Ikotun, KE Henry Molecular Imaging and Biology 25 (2), 265-270, 2023 | | 2023 |
| Dosimetry of [212Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free 208Tl on Tissue Absorbed Doses KD Orcutt, KE Henry, C Habjan, K Palmer, J Heimann, JM Cupido, ... Molecules 27 (18), 5831, 2022 | 2 | 2022 |
| Visions by WIMIN: Global mentorship to retain underrepresented trainees KJ Edwards, E Akam, JN Ijoma, KN Mack, PMR Pereira, S Dhanvantari, ... Molecular Imaging and Biology 24 (4), 519-525, 2022 | 6 | 2022 |
| Noninvasive Imaging of CD4+ T Cells in Humanized Mice VL Nagle, CAJ Hertz, KE Henry, MS Graham, C Campos, N Pillarsetty, ... Molecular cancer therapeutics 21 (4), 658-666, 2022 | 6 | 2022 |
| Imaging of cancer γ-secretase activity using an inhibitor-based PET probe P Nie, T Kalidindi, VL Nagle, X Wu, T Li, GP Liao, G Frost, KE Henry, ... Clinical Cancer Research 27 (22), 6145-6155, 2021 | 7 | 2021 |
| Visions by WIMIN: BIPOC representation matters JN Ijoma, M Sahn, KN Mack, E Akam, KJ Edwards, X Wang, A Surpur, ... Molecular Imaging and Biology, 1-6, 2021 | 19 | 2021 |
| ERK inhibition improves anti–PD-L1 immune checkpoint blockade in preclinical pancreatic ductal adenocarcinoma KE Henry, KN Mack, VL Nagle, M Cornejo, AO Michel, IL Fox, ... Molecular cancer therapeutics 20 (10), 2026-2034, 2021 | 13 | 2021 |
| Exploiting the MUC5AC antigen for noninvasive identification of pancreatic cancer KE Henry, TM Shaffer, KN Mack, J Ring, A Ogirala, S Klein-Scory, ... Journal of Nuclear Medicine 62 (10), 1384-1390, 2021 | 6 | 2021 |
| Visions by women in molecular imaging network: Antiracism and allyship in action E Akam, C Azevedo, AM Chaney, S Dhanvantari, KJ Edwards, KE Henry, ... Molecular Imaging and Biology 23, 301-309, 2021 | 7 | 2021 |
| Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET VL Nagle, KE Henry, CAJ Hertz, MS Graham, C Campos, LF Parada, ... Clinical Cancer Research 27 (7), 1958-1966, 2021 | 28 | 2021 |
| Polyazamacrocycle Ligands Facilitate 89Zr Radiochemistry and Yield 89Zr Complexes with Remarkable Stability DN Pandya, KE Henry, CS Day, SA Graves, VL Nagle, TR Dilling, A Sinha, ... Inorganic chemistry 59 (23), 17473-17487, 2020 | 23 | 2020 |
| 3D-printable platform for high-throughput small-animal imaging LM Carter, KE Henry, A Platzman, JS Lewis Journal of Nuclear Medicine 61 (11), 1691-1692, 2020 | 6 | 2020 |
| Demarcation of sepsis-induced peripheral and central acidosis with pH (low) insertion cycle peptide KE Henry, AM Chaney, VL Nagle, HC Cropper, S Mozaffari, G Slaybaugh, ... Journal of Nuclear Medicine 61 (9), 1361-1368, 2020 | 13 | 2020 |
| Altering the tumor microenvironment to improve immunotherapy: Molecular imaging of PD-L1 in pancreatic cancer K Henry, M Davydova, T Dilling, I Fox, J Lewis ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
| Teaching old ligands new tricks: macrocyclic chelators for zirconium-89 radiochemistry K Henry, D Pandya, B Nikunj, V Nagle, T Dilling, T Wadas, J Lewis Nuclear Medicine and Biology 72, S15, 2019 | | 2019 |
| A PET imaging strategy for interrogating target engagement and oncogene status in pancreatic cancer KE Henry, MM Dacek, TR Dilling, JD Caen, IL Fox, MJ Evans, JS Lewis Clinical Cancer Research 25 (1), 166-176, 2019 | 19 | 2019 |
| Clinical potential of human epidermal growth factor receptor 2 and human epidermal growth factor receptor 3 imaging in breast cancer KE Henry, GA Ulaner, JS Lewis PET clinics 13 (3), 423-435, 2018 | 24 | 2018 |
